PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.70%
Negative net income growth while AVGO stands at 25.66%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-1.96%
Negative yoy D&A while AVGO is 9.52%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
155.56%
Lower deferred tax growth vs. AVGO's 500.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-5.33%
Negative yoy SBC while AVGO is 11.11%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
131.94%
Slight usage while AVGO is negative at -556.25%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
81.25%
AR growth while AVGO is negative at -760.00%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
70.00%
Inventory growth of 70.00% while AVGO is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
52.78%
A yoy AP increase while AVGO is negative at -69.44%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
261.70%
Some yoy usage while AVGO is negative at -520.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
833.33%
Some yoy increase while AVGO is negative at -500.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
70.77%
Some CFO growth while AVGO is negative at -28.27%. John Neff would note a short-term liquidity lead over the competitor.
-27.84%
Both yoy lines negative, with AVGO at -38.30%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
27.84%
Some acquisitions while AVGO is negative at -908.11%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
58.49%
Purchases growth of 58.49% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-69.92%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-24.74%
We reduce yoy other investing while AVGO is 196.43%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-168.39%
Both yoy lines negative, with AVGO at -421.43%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment similar to AVGO's 100.00%. Walter Schloss sees parallel liability management or similar free cash flow availability.
1.75%
Lower share issuance yoy vs. AVGO's 77.78%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-1.80%
Both yoy lines negative, with AVGO at -245.45%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.